Diaryl ethers as opioid receptor antagonist
US7381719B2 · kind B2 · utility
14Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 2003 |
| Grant date | Jun 3, 2008 |
| Priority date | — |
| Expiry date | May 30, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound of the formula (I) wherein the variables X1 to X10, R1 to R7 including R3′, E, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.